Affinity Asset Advisors, LLC Q4 2023 Filing
Filed February 13, 2024
Portfolio Value
$547.5T
Holdings
76
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (76 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | IMGNEURIMMUNOGEN INC | 1,404,608 | $41.6T | 7.61% | |
| 2 | TEVATEVA PHARMACEUTICAL INDS LTD | 3,300,000 | $34.5T | 6.29% | Call |
| 3 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 750,000 | $31.8T | 5.81% | |
| 4 | CBAYUSDCYMABAY THERAPEUTICS INC | 1,090,441 | $25.8T | 4.70% | |
| 5 | MDGLMADRIGAL PHARMACEUTICALS INC | 100,000 | $23.1T | 4.23% | |
| 6 | XENEXENON PHARMACEUTICALS INC | 460,000 | $21.2T | 3.87% | |
| 7 | BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | 17,000,000 | $20.6T | 3.76% | |
| 8 | CRNXCRINETICS PHARMACEUTICALS IN | 541,395 | $19.3T | 3.52% | Put |
| 9 | ACLXARCELLX INC | 340,000 | $18.9T | 3.45% | |
| 10 | LIANYLIANBIO | 3,779,694 | $16.9T | 3.09% | |
| 11 | TCE2CELLDEX THERAPEUTICS INC NEW | 400,000 | $15.9T | 2.90% | |
| 12 | APGEAPOGEE THERAPEUTICS INC | 537,093 | $15.0T | 2.74% | |
| 13 | IMVTIMMUNOVANT INC | 345,000 | $14.5T | 2.65% | |
| 14 | CYTKCYTOKINETICS INC | 160,000 | $13.4T | 2.44% | |
| 15 | NUVLNUVALENT INC | 175,000 | $12.9T | 2.35% | |
| 16 | ESTAESTABLISHMENT LABS HLDGS INC | 453,277 | $11.7T | 2.14% | Call |
| 17 | CATBUSDASTRIA THERAPEUTICS INC | 1,466,465 | $11.3T | 2.06% | |
| 18 | VRNAVERONA PHARMA PLC | 563,824 | $11.2T | 2.05% | |
| 19 | SYRESPYRE THERAPEUTICS INC | 517,554 | $11.1T | 2.03% | |
| 20 | ALKSALKERMES PLC | 383,384 | $10.6T | 1.94% | Put |
| 21 | AUTLAUTOLUS THERAPEUTICS PLC | 1,550,408 | $10.0T | 1.82% | |
| 22 | EYPTEYEPOINT PHARMACEUTICALS INC | 430,000 | $9.9T | 1.81% | Put |
| 23 | INZYINOZYME PHARMA INC | 1,885,802 | $8.0T | 1.47% | |
| 24 | NRIXNURIX THERAPEUTICS INC | 690,112 | $7.1T | 1.30% | |
| 25 | CNTACENTESSA PHARMACEUTICALS PLC | 795,729 | $6.3T | 1.16% | |
| 26 | APLSAPELLIS PHARMACEUTICALS INC | 100,000 | $6.0T | 1.09% | Call |
| 27 | MRTXEURMIRATI THERAPEUTICS INC | 100,049 | $5.9T | 1.07% | |
| 28 | ALNYALNYLAM PHARMACEUTICALS INC | 30,000 | $5.7T | 1.05% | Call |
| 29 | ROIVROIVANT SCIENCES LTD | 500,000 | $5.6T | 1.03% | |
| 30 | VKTXVIKING THERAPEUTICS INC | 300,000 | $5.6T | 1.02% | |
| 31 | YB4PSAVARA INC | 1,150,000 | $5.4T | 0.99% | |
| 32 | CMPSCOMPASS PATHWAYS PLC | 550,000 | $4.8T | 0.88% | |
| 33 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 70,988 | $4.3T | 0.78% | |
| 34 | DVAXDYNAVAX TECHNOLOGIES CORP | 300,000 | $4.2T | 0.77% | |
| 35 | GPCRSTRUCTURE THERAPEUTICS INC | 100,000 | $4.1T | 0.74% | Call |
| 36 | AZNASTRAZENECA PLC | 60,000 | $4.0T | 0.74% | |
| 37 | AXSMAXSOME THERAPEUTICS INC | 50,000 | $4.0T | 0.73% | |
| 38 | SWTXSPRINGWORKS THERAPEUTICS INC | 100,000 | $3.6T | 0.67% | |
| 39 | OMER 5.25 02/15/26OMEROS CORP | 6,000,000 | $3.6T | 0.66% | |
| 40 | —COHERUS BIOSCIENCES INC | 6,000,000 | $3.4T | 0.62% | |
| 41 | RLAYRELAY THERAPEUTICS INC | 300,000 | $3.3T | 0.60% | |
| 42 | BBIOBRIDGEBIO PHARMA INC | 80,000 | $3.2T | 0.59% | |
| 43 | KRYSKRYSTAL BIOTECH INC | 25,000 | $3.1T | 0.57% | |
| 44 | CGEMCULLINAN ONCOLOGY INC | 300,000 | $3.1T | 0.56% | |
| 45 | TNGXTANGO THERAPEUTICS INC | 300,274 | $3.0T | 0.54% | |
| 46 | ARGXARGENX SE | 7,500 | $2.9T | 0.52% | |
| 47 | KURAKURA ONCOLOGY INC | 191,535 | $2.8T | 0.50% | |
| 48 | SAVACASSAVA SCIENCES INC | 121,000 | $2.7T | 0.50% | Call |
| 49 | ASNDASCENDIS PHARMA A/S | 20,000 | $2.5T | 0.46% | |
| 50 | —MERSANA THERAPEUTICS INC | 1,000,000 | $2.3T | 0.42% | |
| 51 | IMTXIMMATICS N.V | 200,000 | $2.1T | 0.38% | |
| 52 | PENPENUMBRA INC | 7,500 | $1.9T | 0.34% | |
| 53 | TRMLTOURMALINE BIO INC | 68,081 | $1.8T | 0.33% | |
| 54 | ADCTADC THERAPEUTICS SA | 1,013,540 | $1.7T | 0.31% | |
| 55 | PCVXVAXCYTE INC | 25,000 | $1.6T | 0.29% | |
| 56 | KALVKALVISTA PHARMACEUTICALS INC | 125,969 | $1.5T | 0.28% | |
| 57 | MIRMMIRUM PHARMACEUTICALS INC | 50,000 | $1.5T | 0.27% | |
| 58 | NAMSNEWAMSTERDAM PHARMA COMPANY | 125,000 | $1.4T | 0.26% | |
| 59 | NBIXNEUROCRINE BIOSCIENCES INC | 10,000 | $1.3T | 0.24% | |
| 60 | NARIUSDINARI MED INC | 20,000 | $1.3T | 0.24% | |
| 61 | ALLOALLOGENE THERAPEUTICS INC | 400,000 | $1.3T | 0.23% | |
| 62 | MORFMORPHIC HLDG INC | 42,670 | $1.2T | 0.23% | |
| 63 | VRDNVIRIDIAN THERAPEUTICS INC | 50,000 | $1.1T | 0.20% | |
| 64 | BHVNBIOHAVEN LTD | 20,866 | $893.1B | 0.16% | |
| 65 | PBYIPUMA BIOTECHNOLOGY INC | 202,349 | $876.2B | 0.16% | |
| 66 | FULCFULCRUM THERAPEUTICS INC | 125,000 | $843.8B | 0.15% | |
| 67 | —AVROBIO INC | 500,000 | $680.0B | 0.12% | |
| 68 | IMTXIMMATICS N.V | 187,204 | $546.6B | 0.10% | |
| 69 | NAMSNEWAMSTERDAM PHARMA COMPANY | 137,000 | $428.8B | 0.08% | |
| 70 | TERNTERNS PHARMACEUTICALS INC | 66,000 | $428.3B | 0.08% | |
| 71 | NUVBNUVATION BIO INC | 250,000 | $377.5B | 0.07% | |
| 72 | CNTXCONTEXT THERAPEUTICS INC | 328,817 | $371.6B | 0.07% | |
| 73 | IFRXINFLARX NV | 200,097 | $326.2B | 0.06% | |
| 74 | PMNEURPROMIS NEUROSCIENCES INC | 265,958 | $305.9B | 0.06% | |
| 75 | VSAREURARAVIVE INC | 346,511 | $42.9B | 0.01% | |
| 76 | RCKTWROCKET PHARMACEUTICALS INC | 75,000 | $36.8B | 0.01% |